INSIGHTS ON DRUG DISCOVERY
-
![GettyImages-2182052428-scientist-research-mack-labs]( "Integrated Drug Discovery: Hit To PCC In 16 Months")
Integrated Drug Discovery: Hit To PCC In 16 MonthsAccelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.
-
![antibody molecules-GettyImages-2165626333]( "ADC Development Grows More Complex — SPR Insights Bring Clarity")
ADC Development Grows More Complex — SPR Insights Bring ClarityExplore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
![mammlian-cell-lines-GettyImages-1690936576]( "Mammalian Cell Line Development")
Mammalian Cell Line DevelopmentExplores how modern cell line engineering boosts speed, stability, and scalability across biologics, with practical insights to cut risk and improve readiness for downstream development.
-
![WuXia293Stable]( "WuXia293Stable: Express What CHO Can't")
WuXia293Stable: Express What CHO Can'tDiscover a modern 293‑based expression system built for higher purity, controlled glycosylation, and improved activity, offering a new option for teams developing complex or next‑generation biologics.
-
What Matters More In DNA-Encoded Libraries?3/16/2026
DELs can screen billions of compounds, but library quality determines meaningful results. See how thoughtful design shapes early decisions that influence which drug candidates move forward.
-
Translating Massive Data Into Therapeutic Momentum3/13/2026
New advances in chemomics, proteome mapping, and modern synthetic methods are redefining how quickly and precisely discovery teams can move from raw data to meaningful clinical momentum.
-
ADCs: Overcoming Analytical Challenges In Next-Gen Cancer Therapies2/24/2026
Antibody-Drug Conjugates (ADCs) represent a revolutionary approach in cancer treatment. But with innovation comes complexity.
-
What FDA CRLs Reveal About E&L2/18/2026
FDA feedback shows E&L gaps still delay approvals. This preview flags common issues — from unknown compounds to weak tox data — and offers ways to strengthen E&L approaches and cut regulatory risk.
-
From Promise To Patients: Smarter Pathways To Scale In Cell And Gene Therapy Manufacturing2/12/2026
As the field evolves, the strategies developers choose may prove just as influential as the therapies themselves in determining how quickly innovation reaches patients.
DRUG DISCOVERY SOLUTIONS
-
![GettyImages-1224202684-laboratory-dna-scientist-research-monitoring]( "TARGATT™ CHO Cells: Rapid, Stable CHO Cell Generation For Bioproduction")
With our proprietary TARGATT™ technology for site-specific integration of large DNA fragments, we’ve developed a series of TARGATT™ “master” cell lines, including engineered CHO.
-
![GettyImages-164198023-cell-line-development]( "Cell Line Development")
Our experience developing mammalian and microbial cell lines and our analytical capabilities enable us to identify and select clones that meet your product’s specific parameters and characteristics.
-
![GettyImages-2223536069 protein]( "TARGATT™ HEK293 Kits")
Accelerate cell line development for library creation and protein expression with efficient TARGATT™ large knock-in technology.
-
![GettyImages-1441786721-mAb-Antibody-monoclonal]( "ADCs: From Design To Development")
Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.
-
![E.coli bacteria growing in dish]( "PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production")
PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.
